Altered glutamate receptor and corticoliberin gene expression in brain regions related to hedonic behavior in rats

Pharmacology Biochemistry and Behavior

Volumn 76, Issue 1, 2003, Pages 9-16

  Duncko, Roman ^a   Schwendt, Marek ^a   Jezova, Daniela ^a  

^a INSTITUTE OF EXPERIMENTAL ENDOCRINOLOGY   (Slovakia)

Author keywords

Anhedonia; CRH; NMDA; Reward; Serotonin; Stress response

Indexed keywords

CITALOPRAM; CORTICOSTERONE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; GLUTAMATE RECEPTOR; HORMONE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; OXYTOCIN; PROOPIOMELANOCORTIN; SUCROSE; VASOPRESSIN;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; BRAIN; CONTROLLED STUDY; DEPRESSION; FOOD PREFERENCE; GENE EXPRESSION; HEDONIC BEHAVIOR; HIPPOCAMPUS; HYPOTHESIS; MALE; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STRESS; VENTRAL TEGMENTUM;

ANIMALS; BRAIN; CORTICOTROPIN-RELEASING HORMONE; FOOD PREFERENCES; GENE EXPRESSION REGULATION; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GLUTAMATE; STRESS; SUCROSE;

ANIMALIA;

EID: 1642383809     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(03)00164-3     Document Type: Article

References (50)

1. Ayensu W.K., Pucilowski O., Mason G.A., Overstreet D.H., Rezvani A.H., Janowsky D.S. Effects of chronic mild stress on serum complement activity, saccharin preference, and corticosterone levels in Flinders lines of rats. Physiol. Behav. 57:1995;165-169.
2. Blackstone C.D., Levey A.I., Martin L.J., Price D.L., Huganir R.L. Immunological detection of glutamate receptor subtypes in human central nervous system. Ann. Neurol. 31:1992;680-683.
3. Bouron A., Chatton J.Y. Acute application of the tricyclic antidepressant desipramine presynaptically stimulates the exocytosis of glutamate in the hippocampus. Neuroscience. 90:1999;729-736.
4. Carlezon W.A. Jr., Todtenkopf M.S., McPhie D.L., Pimentel P., Pliakas A.M., Stellar J.R.et al. Repeated exposure to rewarding brain stimulation downregulates GluR1 expression in the ventral tegmental area. Neuropsychopharmacology. 25:2001;234-241.
5. Charney D.S. Monoamine dysfunction and the pathophysiology and treatment of depression. J. Clin. Psychiatry. 59:1998;11-14.
6. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
7. Cull-Candy S., Brickley S., Farrant M. NMDA receptor subunits: diversity, development and disease. Curr. Opin. Neurobiol. 11:2001;327-335.
8. Desousa N.J., Wunderlich G.R., De Cabo C., Vaccarino F.J. Individual differences in sucrose intake predict behavioral reactivity in rodent models of anxiety. Pharmacol. Biochem. Behav. 60:1998;841-846.
9. DeSousa N.J., Bush D.E., Vaccarino F.J. Self-administration of intravenous amphetamine is predicted by individual differences in sucrose feeding in rats. Psychopharmacology (Berl). 148:2000;52-58.
10. Duncko R., Kiss A., Skultetyova I., Rusnak M., Jezova D. Corticotropin-releasing hormone mRNA levels in response to chronic mild stress rise in male but not in female rats while tyrosine hydroxylase mRNA levels decrease in both sexes. Psychoneuroendocrinology. 26:2001;77-89.
11. Fitzgerald L.W., Ortiz J., Hamedani A.G., Nestler E.J. Drugs of abuse and stress increase the expression of GluR1 and NMDAR1 glutamate receptor subunits in the rat ventral tegmental area: common adaptations among cross-sensitizing agents. J. Neurosci. 16:1996;274-282.
12. Gosnell B.A. Sucrose intake predicts rate of acquisition of cocaine self-administration. Psychopharmacology (Berl). 149:2000;286-292.
13. Gosnell B.A., Lane K.E., Bell S.M., Krahn D.D. Intravenous morphine self-administration by rats with low versus high saccharin preferences. Psychopharmacology (Berl). 117:1995;248-252.
14. Griffiths J., Shanks N., Anisman H. Strain-specific alterations in consumption of a palatable diet following repeated stressor exposure. Pharmacol. Biochem. Behav. 42:1992;219-227.
15. Holsboer F., Barden N. Antidepressants and hypothalamic-pituitary- adrenocortical regulation. Endocr. Rev. 17:1996;187-205.
16. Jacobson L., Sapolsky R. The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis. Endocr. Rev. 12:1991;118-134.
17. Jensen J.B., Jessop D.S., Harbuz M.S., Mork A., Sanchez C., Mikkelsen J.D. Acute and long-term treatments with the selective serotonin reuptake inhibitor citalopram modulate the HPA axis activity at different levels in male rats. J. Neuroendocrinol. 11:1999;465-471.
18. Jezova D., Duncko R. Enhancement of stress-induced pituitary hormone release and cardiovascular activation by antidepressant treatment in healthy men. J. Psychopharmacol. 16:2002;235-240.
19. Jezova D., Kvetnansky R., Kovacs K., Oprsalova Z., Vigas M., Makara G.B. Insulin-induced hypoglycemia activates the release of adrenocorticotropin predominantly via central and propranolol insensitive mechanisms. Endocrinology. 120:1987;409-415.
20. Jezova D., Tokarev D., Rusnak M. Endogenous excitatory amino acids are involved in stress-induced adrenocorticotropin and catecholamine release. Neuroendocrinology. 62:1995;326-332.
21. Kathol R.G., Gehris T.L., Carroll B.T., Samuelson S.D., Pitts A.F., Meller W.H.et al. Blunted ACTH response to hypoglycemic stress in depressed patients but not in patients with schizophrenia. J. Psychiatr. Res. 26:1992;103-116.
22. Katz R.J. Animal model of depression: pharmacological sensitivity of a hedonic deficit. Pharmacol. Biochem. Behav. 16:1982;965-968.
23. Lieblich I., Yirmiya R., Liebeskind J.C. Intake of and preference for sweet solutions are attenuated in morphine-withdrawn rats. Behav. Neurosci. 105:1991;965-970.
24. Moncek F., Kvetnansky R., Jezova D. Differential responses to stress stimuli of Lewis and Fischer rats at the pituitary and adrenocortical level. Endocr. Regul. 35:2001;35-41.
25. Moncek F., Duncko R., Jezova D. Repeated citalopram treatment but not stress exposure attenuates hypothalamic-pituitary-adrenocortical axis response to acute citalopram injection. Life Sci. 72:2003;1353-1365.
26. Papp M., Moryl E. Antidepressant activity of noncompetitive and competitive NMDA receptor antagonists in a chronic mild stress model of depression. Eur. J. Pharmacol. 263:1994;1-7.
27. Pirot S., Glowinski J., Thierry A.M. Mediodorsal thalamic evoked responses in the rat prefrontal cortex: influence of the mesocortical DA system. NeuroReport. 7:1996;1437-1441.
28. Purba J.S., Hoogendijk W.J., Hofman M.A., Swaab D.F. Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression. Arch. Gen. Psychiatry. 53:1996;137-143.
29. Schwendt M., Jezova D. Gene expression of two glutamate receptor subunits in response to repeated stress exposure in rat hippocampus. Cell. Mol. Neurobiol. 20:2000;319-329.
30. Schwendt M., Jezova D. Rise in gene expression of NMDAR1 receptor subunit in rat adrenals after stress exposure. J. Physiol. Pharmacol. 52:2001;719-727.
31. Shors T.J., Seib T.B., Levine S., Thompson R.F. Inescapable versus escapable shock modulates long-term potentiation in the rat hippocampus. Science. 244:1989;224-226.
32. Sills T.L., Crawley J.N. Individual differences in sugar consumption predict amphetamine-induced dopamine overflow in nucleus accumbens. Eur. J. Pharmacol. 303:1996;177-181.
33. Sills T.L., Vaccarino F.J. Individual differences in sugar intake predict the locomotor response to acute and repeated amphetamine administration. Psychopharmacology (Berl). 116:1994;1-8.
34. Sills T.L., Vaccarino F.J. Individual differences in the feeding and locomotor stimulatory effects of acute and repeated morphine treatments. Pharmacol. Biochem. Behav. 60:1998;293-303.
35. Skolnick P., Legutko B., Li X., Bymaster F.P. Current perspectives on the development of nonbiogenic amine-based antidepressants. Pharmacol. Res. 43:2001;411-423.
36. Skultetyova I., Kiss A., Jezova D. Neurotoxic lesions induced by monosodium glutamate result in increased adenopituitary proopiomelanocortin gene expression and decreased corticosterone clearance in rats. Neuroendocrinology. 67:1998;412-420.
37. Smith-Roe S.L., Kelley A.E. Coincident activation of NMDA and dopamine D1 receptors within the nucleus accumbens core is required for appetitive instrumental learning. J. Neurosci. 20:2000;7737-7742.
38. Smith Y., Charara A., Parent A. Synaptic innervation of midbrain dopaminergic neurons by glutamate-enriched terminals in the squirrel monkey. J. Comp. Neurol. 364:1996;231-253.
39. Stout S.C., Mortas P., Owens M.J., Nemeroff C.B., Moreau J. Increased corticotropin-releasing factor concentrations in the bed nucleus of the stria terminalis of anhedonic rats. Eur. J. Pharmacol. 401:2000;39-46.
40. Tracy A.L., Jarrard L.E., Davidson T.L. The hippocampus and motivation revisited: appetite and activity. Behav. Brain Res. 127:2001;13-23.
41. Tzschentke T.M. Pharmacology and behavioral pharmacology of the mesocortical dopamine system. Prog. Neurobiol. 63:2001;241-320.
42. Uvnas-Moberg K., Bjokstrand E., Hillegaart V., Ahlenius S. Oxytocin as a possible mediator of SSRI-induced antidepressant effects. Psychopharmacology (Berl). 142:1999;95-101.
43. Von Frijtag J.C., Reijmers L.G., Van der Harst J.E., Leus I.E., Van den Bos R., Spruijt B.M. Defeat followed by individual housing results in long-term impaired reward and cognition-related behaviours in rats. Behav. Brain Res. 117:2000;137-146.
44. Weiland N.G., Orchinik M., Tanapat P. Chronic corticosterone treatment induces parallel changes in N-methyl-D-aspartate receptor subunit messenger RNA levels and antagonist binding sites in the hippocampus. Neuroscience. 78:1997;653-662.
45. Willner P. Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology (Berl). 134:1997;319-329.
46. Wolf M.E. The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog. Neurobiol. 54:1998;679-720.
47. Yoneda Y., Han D., Ogita K. Preferential induction by stress of the N-methyl-D-aspartate recognition domain in discrete structures of rat brain. J. Neurochem. 63:1994;1863-1871.
48. Young E.A., Lopez J.F., Murphy-Weinberg V., Watson S.J., Akil H. Hormonal evidence for altered responsiveness to social stress in major depression. Neuropsychopharmacology. 23:2000;411-418.
49. Zahorodna A., Bijak M. An antidepressant-induced decrease in the responsiveness of hippocampal neurons to Group I metabotropic glutamate receptor activation. Eur. J. Pharmacol. 386:1999;173-179.
50. Zelena D., Makara G.B., Jezova D. Simultaneous blockade of two glutamate receptor subtypes (NMDA and AMPA) results in stressor-specific inhibition of prolactin and corticotropin release. Neuroendocrinology. 69:1999;316-323.